$4.77
0.163.47%
At Close: -
$4.77
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Alector: Insider buying and selling updated today.
Jun 04, 2024 | Gary Romano | CHIEF MEDICAL OFFICER | -8.04K | $4.80 | -$38.58K | SELL | -4.10% | 188.273K | Jun 03 | View |
Jun 04, 2024 | Sara KenkareMitra | PRESIDENT AND HEAD R&D | -13.206K | $4.80 | -$63.37K | SELL | -4.14% | 305.641K | Jun 03 | View |
Jun 04, 2024 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -25.135K | $4.80 | -$120.62K | SELL | -0.95% | 2.627745M | Jun 03 | View |
Jun 04, 2024 | Marc Grasso | CHIEF FINANCIAL OFFICER | -6.92K | $4.80 | -$33.21K | SELL | -4.77% | 138.037K | Jun 03 | View |
Mar 05, 2024 | Marc Grasso | CHIEF FINANCIAL OFFICER | -5.716K | $6.92 | -$39.56K | SELL | -3.79% | 144.957K | Mar 04 | View |
Mar 05, 2024 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -18.837K | $6.92 | -$130.39K | SELL | -0.71% | 2.65288M | Mar 04 | View |
Mar 05, 2024 | Gary Romano | CHIEF MEDICAL OFFICER | -6.001K | $6.92 | -$41.55K | SELL | -2.97% | 196.313K | Mar 04 | View |
Mar 05, 2024 | Sara KenkareMitra | PRESIDENT AND HEAD R&D | -10.169K | $6.92 | -$70.39K | SELL | -3.09% | 318.847K | Mar 04 | View |
Dec 06, 2023 | Marc Grasso | CHIEF FINANCIAL OFFICER | -4.574K | $5.56 | -$25.43K | SELL | -2.95% | 150.673K | Dec 04 | View |
Dec 06, 2023 | Gary Romano | CHIEF MEDICAL OFFICER | -5.035K | $5.56 | -$27.99K | SELL | -2.43% | 202.314K | Dec 04 | View |
Dec 06, 2023 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -23.831K | $5.56 | -$132.50K | SELL | -0.88% | 2.671717M | Dec 04 | View |
Dec 06, 2023 | Sara KenkareMitra | PRESIDENT AND HEAD R&D | -12.519K | $5.56 | -$69.61K | SELL | -3.67% | 329.016K | Dec 04 | View |
Sep 13, 2023 | Polaris Venture Management Co VI LLCPolaris Venture Partners VI AIV LPPolaris Venture Partners Founders Fund VI LPPolaris Venture Partners VI LPPolaris Venture Partners VI AIVB LP | 10% OWNER | -500K | $6.00 | -$3.00M | SELL | -4.40% | 10.853817M | Sep 11 | View |
Sep 13, 2023 | Terrance McGuire | DIRECTOR | -500K | $6.00 | -$3.00M | SELL | -4.39% | 10.893216M | Sep 11 | View |
Sep 06, 2023 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -5.647K | $5.19 | -$29.33K | SELL | -0.25% | 2.297948M | Sep 05 | View |
Sep 06, 2023 | Sara KenkareMitra | PRESIDENT AND HEAD R&D | -6.214K | $5.19 | -$32.28K | SELL | -3.37% | 177.935K | Sep 05 | View |
Sep 06, 2023 | Gary Romano | CHIEF MEDICAL OFFICER | -2.771K | $5.19 | -$14.39K | SELL | -2.71% | 99.349K | Sep 05 | View |
Sep 06, 2023 | Marc Grasso | CHIEF FINANCIAL OFFICER | -1.114K | $5.19 | -$5.79K | SELL | -3.34% | 32.247K | Sep 05 | View |
Jun 05, 2023 | Sara KenkareMitra | PRESIDENT AND HEAD R&D | -4.092K | $6.90 | -$28.25K | SELL | -2.17% | 184.149K | Jun 02 | View |
Jun 05, 2023 | Marc Grasso | CHIEF FINANCIAL OFFICER | -1.05K | $6.90 | -$7.25K | SELL | -3.05% | 33.361K | Jun 02 | View |
Jun 05, 2023 | Gary Romano | CHIEF MEDICAL OFFICER | -2.617K | $6.90 | -$18.07K | SELL | -2.50% | 102.12K | Jun 02 | View |
Jun 05, 2023 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -5.255K | $6.90 | -$36.28K | SELL | -0.23% | 2.303595M | Jun 02 | View |
Mar 21, 2023 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | 27.804K | $6.22 | -$94.43K | GRANT | 1.22% | 2.30885M | Mar 03 - Mar 17 | View |
Mar 03, 2023 | Gary Romano | CHIEF MEDICAL OFFICER | -5.383K | $8.47 | -$45.61K | SELL | -4.89% | 104.737K | Dec 02 - Mar 02 | View |
Mar 03, 2023 | Sara KenkareMitra | PRESIDENT AND HEAD R&D | -10.124K | $8.32 | -$84.22K | SELL | -5.10% | 188.241K | Mar 02 | View |
Mar 03, 2023 | Marc Grasso | CHIEF FINANCIAL OFFICER | -1.291K | $8.32 | -$10.74K | SELL | -3.62% | 34.411K | Mar 02 | View |
Mar 03, 2023 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -5.849K | $8.32 | -$48.65K | SELL | -0.26% | 2.281046M | Mar 02 | View |
Sep 07, 2022 | Gary Romano | CHIEF MEDICAL OFFICER | -2.177K | $10.62 | -$23.12K | SELL | -2.36% | 90.073K | Sep 02 | View |
Sep 07, 2022 | Robert King | CHIEF DEVELOPMENT OFFICER | -176 | $10.62 | -$1.87K | SELL | -0.03% | 529.295K | Sep 02 | View |
Jun 06, 2022 | Robert King | CHIEF DEVELOPMENT OFFICER | -177 | $8.71 | -$1.54K | SELL | -0.03% | 529.471K | Jun 02 | View |
Mar 03, 2022 | Robert King | CHIEF DEVELOPMENT OFFICER | -287 | $15.57 | -$4.47K | SELL | -0.05% | 528.404K | Mar 01 | View |
Dec 14, 2021 | SHEHNAAZ SULIMAN | PRESIDENT AND COO | 0 | $19.37 | -$640.82K | SELL-OPTIONS | 0.00% | 102.598K | Dec 10 - Dec 13 | View |
Dec 10, 2021 | SHEHNAAZ SULIMAN | PRESIDENT AND COO | 0 | $18.73 | -$1.22M | SELL-OPTIONS | 0.00% | 102.598K | Dec 08 - Dec 09 | View |
Dec 03, 2021 | Robert King | CHIEF DEVELOPMENT OFFICER | -250 | $20.09 | -$5.02K | SELL | -0.05% | 528.691K | Dec 01 | View |
Nov 12, 2021 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -110K | $25.00 | -$2.75M | SELL | -3.11% | 3.428101M | Nov 10 - Nov 11 | View |
Nov 10, 2021 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -200K | $25.00 | -$5.00M | SELL | -8.67% | 2.107726M | Nov 08 - Nov 09 | View |
Nov 08, 2021 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -200K | $25.00 | -$5.00M | SELL | -8.56% | 2.137726M | Nov 04 - Nov 05 | View |
Sep 23, 2021 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -109.625K | $25.31 | -$2.77M | SELL | -3.51% | 3.015375M | Sep 22 - Sep 23 | View |
Sep 22, 2021 | Arnon Rosenthal | CHIEF EXECUTIVE OFFICER | -200K | $25.96 | -$5.19M | SELL | -6.02% | 3.125M | Sep 20 - Sep 21 | View |
Aug 11, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $18.93 | -$378.52K | SELL-OPTIONS | 0.00% | 234.319K | Aug 09 | View |
Aug 09, 2021 | RICHARD SCHELLER | DIRECTOR | -9.981K | $19.17 | -$1.30M | SELL | -100.00% | 0 | Jul 02 - Aug 05 | View |
Jul 08, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $26.33 | -$1.39M | SELL-OPTIONS | 0.00% | 234.319K | Jul 06 - Jul 07 | View |
Jul 07, 2021 | Calvin Yu | VICE PRESIDENT, FINANCE | -50K | $22.96 | -$2.90M | SELL | -39.47% | 76.686K | Jul 02 - Jul 06 | View |
Jul 07, 2021 | Robert King | CHIEF DEVELOPMENT OFFICER | 0 | $20.14 | -$1.32M | SELL-OPTIONS | 0.00% | 522.317K | Jul 02 | View |
Jul 06, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | -39.4K | $22.05 | -$1.23M | SELL | -14.39% | 234.319K | Jul 01 - Jul 02 | View |
Jun 21, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $15.62 | -$447.02K | SELL-OPTIONS | 0.00% | 273.719K | Jun 15 - Jun 16 | View |
Jun 10, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $14.28 | -$187.75K | SELL-OPTIONS | 0.00% | 273.719K | Jun 08 | View |
Jun 03, 2021 | Calvin Yu | VICE PRESIDENT, FINANCE | -1.844K | $17.77 | -$32.77K | SELL | -1.43% | 126.686K | Jun 02 | View |
May 25, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $13.20 | -$147.93K | SELL-OPTIONS | 0.00% | 273.719K | May 21 | View |
May 20, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $13.41 | -$38.94K | SELL-OPTIONS | 0.00% | 273.719K | May 18 | View |
Apr 08, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $14.40 | -$213.86K | SELL-OPTIONS | 0.00% | 213.719K | Apr 07 | View |
Mar 24, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $15.45 | -$638.47K | SELL-OPTIONS | 0.00% | 213.719K | Mar 22 - Mar 23 | View |
Mar 10, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $13.25 | -$186.81K | SELL-OPTIONS | 0.00% | 213.719K | Mar 09 | View |
Feb 11, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $14.59 | -$238.46K | SELL-OPTIONS | 0.00% | 213.719K | Feb 09 | View |
Jan 27, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $13.19 | -$551.76K | SELL-OPTIONS | 0.00% | 213.719K | Jan 25 - Jan 26 | View |
Jan 21, 2021 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $13.23 | -$374.81K | SELL-OPTIONS | 0.00% | 213.719K | Jan 19 - Jan 20 | View |
Jul 17, 2020 | Robert Paul | — | -10K | $22.96 | -$229.64K | SELL | -4.47% | 213.719K | Jul 15 | View |
Jun 25, 2020 | Terrance McGuire | — | -4.377K | $31.54 | -$138.06K | SELL | -0.03% | 12.853817M | Jun 23 | View |
Jun 25, 2020 | Polaris Venture Management Co VI LLCPolaris Venture Partners VI AIV LPPolaris Venture Partners Founders Fund VI LPPolaris Venture Partners VI LPPVP VI AIV Feeder Corp Holding Partnership LP | — | -4.377K | $31.54 | -$138.06K | SELL | -0.03% | 12.853817M | Jun 23 | View |
Jun 17, 2020 | Robert Paul | — | -10K | $29.61 | -$296.14K | SELL | -4.28% | 223.719K | Jun 15 | View |
Jun 05, 2020 | Calvin Yu | — | -1.343K | $31.26 | -$41.98K | SELL | -1.20% | 110.686K | Jun 03 | View |
May 19, 2020 | Robert Paul | — | -10K | $27.00 | -$270.03K | SELL | -4.10% | 233.719K | May 15 | View |
May 19, 2020 | Robert King | — | -15K | $27.00 | -$404.96K | SELL | -3.05% | 477.317K | May 15 | View |
Apr 17, 2020 | Robert Paul | — | -10K | $22.27 | -$222.70K | SELL | -3.94% | 243.719K | Apr 15 | View |
Apr 16, 2020 | ORBIMED ADVISORS LLCOrbiMed Capital GP IV LLC | — | -85.414K | $23.53 | -$2.01M | SELL | -4.29% | 1.906718M | Apr 14 - Apr 16 | View |
Apr 09, 2020 | ORBIMED ADVISORS LLCOrbiMed Capital GP IV LLC | — | -379.885K | $23.74 | -$9.02M | SELL | -16.46% | 1.92744M | Apr 07 - Apr 09 | View |
Apr 02, 2020 | ORBIMED ADVISORS LLCOrbiMed Capital GP IV LLC | — | -250K | $24.50 | -$6.13M | SELL | -11.02% | 2.019598M | Mar 31 | View |
Mar 25, 2020 | ORBIMED ADVISORS LLCOrbiMed Capital GP IV LLC | — | -138.653K | $24.70 | -$3.43M | SELL | -6.25% | 2.080243M | Mar 23 - Mar 25 | View |
Mar 17, 2020 | Robert Paul | — | -10K | $22.93 | -$229.29K | SELL | -3.79% | 253.719K | Mar 13 | View |
Mar 04, 2020 | ORBIMED ADVISORS LLCOrbiMed Capital GP IV LLCORBIMED CAPITAL LLC | — | -1.874203M | $26.00 | -$48.73M | SELL | -100.00% | 0 | Mar 02 | View |
Feb 18, 2020 | Robert King | — | -15K | $29.56 | -$443.38K | SELL | -2.96% | 492.317K | Feb 14 | View |
Feb 18, 2020 | Robert Paul | — | -10K | $29.54 | -$295.39K | SELL | -3.65% | 263.719K | Feb 14 | View |
Feb 11, 2020 | Sabah Oney | — | -19.9K | $35.03 | -$697.10K | SELL | -3.35% | 573.918K | Feb 07 | View |
Feb 10, 2020 | Calvin Yu | — | -14.608K | $22.26 | -$818.99K | OPTION EXERCISE | -11.66% | 110.686K | Feb 06 - Feb 07 | View |
Feb 07, 2020 | Robert Paul | — | 0 | $20.13 | -$239.40K | OPTION EXERCISE | 0.00% | 273.719K | Feb 05 | View |
Feb 06, 2020 | Sabah Oney | — | -100 | $19.09 | -$367.51K | OPTION EXERCISE | -0.02% | 593.818K | Feb 04 - Feb 06 | View |
Feb 06, 2020 | RICHARD SCHELLER | — | -10K | $29.67 | -$296.70K | SELL | -50.05% | 9.981K | Feb 04 | View |
Feb 06, 2020 | Calvin Yu | — | -50K | $19.10 | -$1.80M | OPTION EXERCISE | -28.52% | 125.294K | Feb 04 | View |
Feb 03, 2020 | David Wehner | — | 20K | $25.00 | $500.00K | PURCHASE | 81.23% | 44.621K | Feb 03 | View |
Feb 03, 2020 | Robert Paul | — | 0 | $18.08 | -$158.72K | OPTION EXERCISE | 0.00% | 273.719K | Jan 30 | View |
Jan 27, 2020 | Sabah Oney | — | 0 | $16.62 | -$281.86K | OPTION EXERCISE | 0.00% | 593.918K | Jan 23 - Jan 27 | View |
Jan 27, 2020 | Robert Paul | — | 0 | $16.24 | -$96.96K | OPTION EXERCISE | 0.00% | 273.719K | Jan 23 | View |
Jan 23, 2020 | Robert King | — | -15K | $22.01 | -$330.15K | SELL | -2.87% | 507.317K | Jan 21 - Jan 22 | View |
Jan 17, 2020 | Robert Paul | — | -10K | $18.67 | -$186.70K | SELL | -3.52% | 273.719K | Jan 15 | View |
Jan 13, 2020 | ORBIMED ADVISORS LLCOrbiMed Capital GP IV LLCORBIMED CAPITAL LLC | — | -379.997K | $19.50 | -$7.41M | SELL | -90.73% | 38.808K | Jan 09 | View |
Dec 26, 2019 | ORBIMED ADVISORS LLCOrbiMed Capital GP IV LLCORBIMED CAPITAL LLC | 10% OWNER | -519.385K | $19.66 | -$10.21M | SELL | -92.82% | 40.2K | Dec 20 - Dec 26 | View |
Dec 19, 2019 | ORBIMED ADVISORS LLCOrbiMed Capital GP IV LLCORBIMED CAPITAL LLC | 10% OWNER | -954.1K | $18.52 | -$17.67M | SELL | -90.71% | 97.7K | Dec 17 | View |
Dec 17, 2019 | Robert Paul | CHIEF MEDICAL OFFICER | -10K | $20.03 | -$200.30K | SELL | -3.40% | 283.719K | Dec 13 | View |
Dec 16, 2019 | Sabah Oney | CHIEF BUSINESS OFFICER | 0 | $14.14 | -$81.50K | SELL-OPTIONS | 0.00% | 593.918K | Dec 12 | View |
Dec 12, 2019 | Sabah Oney | CHIEF BUSINESS OFFICER | 0 | $14.09 | -$5.92K | SELL-OPTIONS | 0.00% | 593.918K | Dec 10 | View |
Dec 09, 2019 | Sabah Oney | CHIEF BUSINESS OFFICER | 0 | $14.09 | -$106.30K | SELL-OPTIONS | 0.00% | 593.918K | Dec 05 - Dec 09 | View |
Dec 05, 2019 | Calvin Yu | VICE PRESIDENT, FINANCE | -1.315K | $18.31 | -$24.08K | SELL | -0.74% | 175.294K | Dec 03 | View |
Nov 19, 2019 | Robert King | CHIEF DEVELOPMENT OFFICER | -7.5K | $15.92 | -$119.40K | SELL | -1.42% | 522.317K | Nov 15 | View |
Nov 19, 2019 | Robert Paul | CHIEF MEDICAL OFFICER | -10K | $15.93 | -$159.30K | SELL | -3.29% | 293.719K | Nov 15 | View |
Oct 17, 2019 | Robert Paul | CHIEF MEDICAL OFFICER | -10K | $14.68 | -$146.80K | SELL | -3.21% | 301.719K | Oct 15 | View |
Sep 24, 2019 | Sabah Oney | CHIEF BUSINESS OFFICER | 0 | $14.08 | -$4.74K | SELL-OPTIONS | 0.00% | 593.918K | Sep 20 | View |
Sep 24, 2019 | Robert Paul | CHIEF MEDICAL OFFICER | 0 | $14.08 | -$47.36K | SELL-OPTIONS | 0.00% | 311.719K | Sep 20 | View |
Sep 18, 2019 | Robert Paul | CHIEF MEDICAL OFFICER | -10K | $19.08 | -$190.80K | SELL | -3.11% | 311.719K | Sep 16 | View |
Aug 21, 2019 | Robert King | CHIEF DEVELOPMENT OFFICER | -7.5K | $15.00 | -$112.50K | SELL | -1.40% | 529.817K | Aug 19 | View |
Aug 21, 2019 | Robert Paul | CHIEF MEDICAL OFFICER | -2K | $16.00 | -$32.00K | SELL | -0.62% | 321.719K | Aug 19 - Aug 20 | View |
Aug 19, 2019 | Robert Paul | CHIEF MEDICAL OFFICER | -10K | $14.19 | -$141.90K | SELL | -3.00% | 323.719K | Aug 15 | View |
Aug 09, 2019 | ORBIMED ADVISORS LLCOrbiMed Capital GP IV LLCORBIMED CAPITAL LLC | 10% OWNER | -650K | $17.90 | -$11.63M | SELL | -17.01% | 3.171804M | Aug 07 | View |
Browse insider trades on all stocks.